Authors
Dr Annette Alfonzo
Consultant Nephrologist. Faculty member of European Resuscitation Council. Victoria Hospital Kirkcaldy, Fife
Dr Alex Harrison
Consultant in Nephrology and Intensive Care. University Hospitals Sussex NHS Foundation Trust
Dr Richard Baines
Consultant Nephrologist and Head of Renal and Transplant Service. University Hospitals of Leicester NHS Trust
Dr Ann Chu
Academic Clinical Fellow Renal Medicine and Medical Education. Imperial College London
Mr Simon Mann
Renal Pharmacist. Lancashire Teaching Hospitals NHS Foundation Trust
Mr Murdoch MacRury
Patient representative
The National Institute for Health and Care Excellence (NICE) has accredited the process used by the UK Kidney Association to produce its Clinical Practice Guidelines. Accreditation is valid for 7 years from January 2017. More information on accreditation can be viewed at www.nice.org.uk/accreditation
Method used to arrive at a recommendation The recommendations for the first draft of this guideline resulted from a collective decision reached by informal discussion by the authors and, whenever necessary, with input from the Chair of the Clinical Practice Guidelines Committee. If no agreement had been reached on the appropriate grading of a recommendation, a vote would have been held and the majority opinion carried. However this was not necessary for this guideline.
All authors made declarations of interest in line with the policy in the UK Kidney Association Clinical Practice Guidelines Development Manual. Further details can be obtained on request from the UK Kidney Association
The authors wish to thank Dr Charlie Tomson, retired Consultant Nephrologist and former Chair of the UK Renal Association (2010-2012), Professor Ketan Dhatariya, Chair of the Joint British Diabetes Society for InPatient Care (JBDS-IP), Dr Clare Crowley, Consultant Pharmacist (Medicines Safety) at Oxford University Hospitals and Mr Murdoch MacRury for his insight into the treatment of hyperkalaemia from a patient’s perspective.
We also wish to acknowledge the contributions of the original writing group whose collaborative efforts produced the 2014 Hyperkalaemia guideline.